Friday, October 3, 2014

Hospira Warned Over Manufacturing Violations at Australian Injectables Plant

Hospira Warned Over Manufacturing Violations at Australian Injectables Plant

The FDA issued a warning letter to injectables giant Hospira after an investigation of its Victoria, Australia, plant uncovered significant good manufacturing practice violations, including a failure to adequately investigate failed batches and determine levels of impurities in distributed products. Read More

1 comment:

Anonymous said...

1.5 YEAR lag in communications to healthcare providers--and that was not from first awareness of the particle concern…